Back to: products

Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

PrintEmail
Aug 2020 - 187 Pages - From $3,800
(Excel Data Sheet: $1,800)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global oral antibiotics market will reach $26.67 billion by 2030, growing by 4.0% annually over 2020-2030 driven by rising complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure.
Highlighted with 89 tables and 97 figures, this 187-page report “Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Cephalosporin
• Cefuroxime Axetil
• Cephalexin
• Cefixime
• Cefpodoxime
• Other Cephalosporin
Penicillin
Macrolides
Tetracycline
Quinolones
Sulfonamides
Aminoglycosides
Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Cell Wall Synthesis Inhibitors
• Mycolic Acid Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Natural Antibiotics
• Semi-synthetic Antibiotics
• Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Broad-spectrum Antibiotics
• Narrow-spectrum Antibiotics

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Urinary Tract Infections (UTIS)
• Upper Respiratory Tract Infections (URTI)
• Lower Respiratory Tract Infections (LRTIs)
Dental Infections
• Monotherapies
• Combined Therapies
Respiratory Tract Infections (RTIS)
Other Applications

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Brand Antibiotics
• Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global oral antibiotics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories 
Astellas Pharma 
AstraZeneca Plc 
Bayer AG 
Bristol Myers Squibb Company 
Cipla Inc. 
Dr. Reddy’s Laboratories Ltd. 
Eli Lilly and Company 
F. Hoffmann-La Roche Ltd. 
Gilead Sciences, Inc. 
GlaxoSmithKline plc. 
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 
Mayne Pharma Group Ltd. 
MELINTA THERAPEUTICS, INC. 
Merck KGaA 
Novartis AG 
Pfizer Inc. 
Sanofi 
Sun Pharmaceutical Industries Ltd. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Global Market by Drug Class 41
3.1 Market Overview by Drug Class 41
3.2 Cephalosporin 43
3.3 Penicillin 45
3.4 Macrolides 46
3.5 Tetracycline 47
3.6 Quinolones 48
3.7 Sulfonamides 49
3.8 Aminoglycosides 50
3.9 Other Drug Classes 51
4 Segmentation of Global Market by Action Mechanism 52
4.1 Market Overview by Action Mechanism 52
4.2 Cell Wall Synthesis Inhibitors 54
4.3 Mycolic Acid Inhibitors 55
4.4 RNA Synthesis Inhibitors 56
4.5 DNA Synthesis Inhibitors 57
4.6 Protein Synthesis Inhibitors 58
4.7 Other Mechanisms 59
5 Segmentation of Global Market by Drug Origin 60
5.1 Market Overview by Drug Origin 60
5.2 Natural Antibiotics 62
5.3 Semi-synthetic Antibiotics 63
5.4 Synthetic Antibiotics 64
6 Segmentation of Global Market by Activity Spectrum 65
6.1 Market Overview by Activity Spectrum 65
6.2 Broad-spectrum Antibiotics 67
6.3 Narrow-spectrum Antibiotics 68
7 Segmentation of Global Market by Application 69
7.1 Market Overview by Application 69
7.2 Urinary Tract Infections (UTIS) 71
7.3 Dental Infections 72
7.3.1 Monotherapies for Dental Infections 73
7.3.2 Combined Therapies for Dental Infections 74
7.4 Respiratory Tract Infections (RTIS) 75
7.4.1 Upper Respiratory Tract Infections (URTI) 76
7.4.2 Lower Respiratory Tract Infections (LRTIs) 77
7.5 Other Applications 78
8 Segmentation of Global Market by Drug Type 79
8.1 Market Overview by Drug Type 79
8.2 Brand Antibiotics 81
8.3 Generic Antibiotics 82
9 Segmentation of Global Market by Region 83
9.1 Geographic Market Overview 2019-2030 83
9.2 North America Market 2019-2030 by Country 89
9.2.1 Overview of North America Market 89
9.2.2 U.S. 93
9.2.3 Canada 97
9.2.4 Mexico 99
9.3 European Market 2019-2030 by Country 101
9.3.1 Overview of European Market 101
9.3.2 Germany 105
9.3.3 UK 107
9.3.4 France 109
9.3.5 Spain 111
9.3.6 Italy 113
9.3.7 Russia 115
9.3.8 Rest of European Market 117
9.4 Asia-Pacific Market 2019-2030 by Country 119
9.4.1 Overview of Asia-Pacific Market 119
9.4.2 Japan 123
9.4.3 China 126
9.4.4 Australia 128
9.4.5 India 130
9.4.6 South Korea 132
9.4.7 Rest of APAC Region 134
9.5 South America Market 2019-2030 by Country 136
9.5.1 Argentina 139
9.5.2 Brazil 141
9.5.3 Chile 143
9.5.4 Rest of South America Market 145
9.6 MEA Market 2019-2030 by Country 146
9.6.1 UAE 149
9.6.2 Saudi Arabia 151
9.6.3 South Africa 153
9.6.4 Other National Markets 155
10 Competitive Landscape 156
10.1 Overview of Key Vendors 156
10.2 New Product Launch, Partnership, Investment, and M&A 160
10.3 Company Profiles 161
Abbott Laboratories 161
Astellas Pharma 163
AstraZeneca Plc 164
Bayer AG 165
Bristol Myers Squibb Company 166
Cipla Inc. 167
Dr. Reddy’s Laboratories Ltd. 168
Eli Lilly and Company 169
F. Hoffmann-La Roche Ltd. 170
Gilead Sciences, Inc. 171
GlaxoSmithKline plc. 172
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 173
Mayne Pharma Group Ltd. 174
MELINTA THERAPEUTICS, INC. 175
Merck KGaA 176
Novartis AG 177
Pfizer Inc. 178
Sanofi 179
Sun Pharmaceutical Industries Ltd. 180
11 Investing in Global Market: Risk Assessment and Management 181
11.1 Risk Evaluation of Global Market 181
11.2 Critical Success Factors (CSFs) 184
Related Reports and Products 187

List of Tables:

Table 1.  Snapshot of Global Oral Antibiotics Market, 2019-2030 21
Table 2.  Main Product Trends and Market Opportunities in Global Oral Antibiotics Market 33
Table 3. Global Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 41
Table 4. Global Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, $ mn 44
Table 5. Global Oral Antibiotics Market by Action Mechanism, 2019-2030, $ mn 52
Table 6. Global Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 60
Table 7. Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, $ mn 65
Table 8. Global Oral Antibiotics Market by Application, 2019-2030, $ mn 69
Table 9. Global Oral Antibiotics Market: Dental Infections by Type, 2019-2030, $ mn 72
Table 10. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, $ mn 75
Table 11. Global Oral Antibiotics Market by Drug Type, 2019-2030, $ bn 79
Table 12. Global Oral Antibiotics Market by Region, 2019-2030, $ bn 84
Table 13. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 86
Table 14.  Leading National Oral Antibiotics Market, 2019 and 2030, $ bn 88
Table 15. North America Oral Antibiotics Market by Country, 2019-2030, $ bn 91
Table 16. U.S. Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 95
Table 17. U.S. Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 95
Table 18. U.S. Oral Antibiotics Market by Application, 2019-2030, $ mn 95
Table 19. Canada Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 98
Table 20. Canada Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 98
Table 21. Canada Oral Antibiotics Market by Application, 2019-2030, $ mn 98
Table 22. Mexico Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 100
Table 23. Mexico Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 100
Table 24. Mexico Oral Antibiotics Market by Application, 2019-2030, $ mn 100
Table 25. Europe Oral Antibiotics Market by Country, 2019-2030, $ bn 104
Table 26. Germany Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 106
Table 27. Germany Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 106
Table 28. Germany Oral Antibiotics Market by Application, 2019-2030, $ mn 106
Table 29. UK Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 108
Table 30. UK Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 108
Table 31. UK Oral Antibiotics Market by Application, 2019-2030, $ mn 108
Table 32. France Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 110
Table 33. France Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 110
Table 34. France Oral Antibiotics Market by Application, 2019-2030, $ mn 110
Table 35. Spain Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 112
Table 36. Spain Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 112
Table 37. Spain Oral Antibiotics Market by Application, 2019-2030, $ mn 112
Table 38. Italy Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 114
Table 39. Italy Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 114
Table 40. Italy Oral Antibiotics Market by Application, 2019-2030, $ mn 114
Table 41. Russia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 116
Table 42. Russia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 116
Table 43. Russia Oral Antibiotics Market by Application, 2019-2030, $ mn 116
Table 44. Oral Antibiotics Market in Rest of Europe by Country, 2019-2030, $ bn 118
Table 45. APAC Oral Antibiotics Market by Country, 2019-2030, $ bn 121
Table 46. Japan Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 125
Table 47. Japan Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 125
Table 48. Japan Oral Antibiotics Market by Application, 2019-2030, $ mn 125
Table 49. China Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 127
Table 50. China Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 127
Table 51. China Oral Antibiotics Market by Application, 2019-2030, $ mn 127
Table 52. Australia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 129
Table 53. Australia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 129
Table 54. Australia Oral Antibiotics Market by Application, 2019-2030, $ mn 129
Table 55. India Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 131
Table 56. India Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 131
Table 57. India Oral Antibiotics Market by Application, 2019-2030, $ mn 131
Table 58. South Korea Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 133
Table 59. South Korea Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 133
Table 60. South Korea Oral Antibiotics Market by Application, 2019-2030, $ mn 133
Table 61. Oral Antibiotics Market in Rest of APAC by Country, 2019-2030, $ bn 135
Table 62. South America Oral Antibiotics Market by Country, 2019-2030, $ bn 138
Table 63. Argentina Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 140
Table 64. Argentina Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 140
Table 65. Argentina Oral Antibiotics Market by Application, 2019-2030, $ mn 140
Table 66. Brazil Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 142
Table 67. Brazil Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 142
Table 68. Brazil Oral Antibiotics Market by Application, 2019-2030, $ mn 142
Table 69. Chile Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 144
Table 70. Chile Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 144
Table 71. Chile Oral Antibiotics Market by Application, 2019-2030, $ mn 144
Table 72. MEA Oral Antibiotics Market by Country, 2019-2030, $ bn 148
Table 73. UAE Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 150
Table 74. UAE Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 150
Table 75. UAE Oral Antibiotics Market by Application, 2019-2030, $ mn 150
Table 76. Saudi Arabia Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 152
Table 77. Saudi Arabia Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 152
Table 78. Saudi Arabia Oral Antibiotics Market by Application, 2019-2030, $ mn 152
Table 79. South Africa Oral Antibiotics Market by Drug Class, 2019-2030, $ mn 154
Table 80. South Africa Oral Antibiotics Market by Drug Origin, 2019-2030, $ mn 154
Table 81. South Africa Oral Antibiotics Market by Application, 2019-2030, $ mn 154
Table 82. Breakdown of Global Market by Key Vendor, 2019, % 158
Table 83. Abbott Laboratories: Company Snapshot 161
Table 84. Abbott Laboratories: Business Segmentation 161
Table 85. Abbott Laboratories: Product Portfolio 162
Table 86. Abbott Laboratories: Revenue, 2016-2018, $ mn 162
Table 87. Abbott Laboratories: Recent Developments 162
Table 88.  Risk Evaluation for Investing in Global Market, 2019-2030 182
Table 89. Critical Success Factors and Key Takeaways 185



List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Breakdown of Primary Research 16
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20
Figure 5. Global Oral Antibiotics Market, 2019-2030, $ mn 23
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Global Oral Antibiotics Market 26
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 29
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 29
Figure 10. Primary Restraints and Impact Factors of Global Oral Antibiotics Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porter’s Fiver Forces Analysis of Global Oral Antibiotics Market 37
Figure 13. Breakdown of Global Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 42
Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value ($ mn) and Share (%) 42
Figure 15. Global Oral Antibiotics Market: Cephalosporin, 2019-2030, $ mn 43
Figure 16. Global Oral Antibiotics Market: Penicillin, 2019-2030, $ mn 45
Figure 17. Global Oral Antibiotics Market: Macrolides, 2019-2030, $ mn 46
Figure 18. Global Oral Antibiotics Market: Tetracycline, 2019-2030, $ mn 47
Figure 19. Global Oral Antibiotics Market: Quinolones, 2019-2030, $ mn 48
Figure 20. Global Oral Antibiotics Market: Sulfonamides, 2019-2030, $ mn 49
Figure 21. Global Oral Antibiotics Market: Aminoglycosides, 2019-2030, $ mn 50
Figure 22. Global Oral Antibiotics Market: Other Drug Classes, 2019-2030, $ mn 51
Figure 23. Breakdown of Global Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 53
Figure 24. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value ($ mn) and Share (%) 53
Figure 25. Global Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, $ mn 54
Figure 26. Global Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, $ mn 55
Figure 27. Global Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, $ mn 56
Figure 28. Global Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, $ mn 57
Figure 29. Global Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, $ mn 58
Figure 30. Global Oral Antibiotics Market: Other Mechanisms, 2019-2030, $ mn 59
Figure 31. Breakdown of Global Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 61
Figure 32. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value ($ mn) and Share (%) 61
Figure 33. Global Oral Antibiotics Market: Natural Antibiotics, 2019-2030, $ mn 62
Figure 34. Global Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, $ mn 63
Figure 35. Global Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, $ mn 64
Figure 36. Breakdown of Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 66
Figure 37. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value ($ mn) and Share (%) 66
Figure 38. Global Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, $ mn 67
Figure 39. Global Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, $ mn 68
Figure 40. Breakdown of Global Oral Antibiotics Market by Application, 2019-2030, % of Revenue 70
Figure 41. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 70
Figure 42. Global Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, $ mn 71
Figure 43. Global Oral Antibiotics Market: Dental Infections, 2019-2030, $ mn 72
Figure 44. Global Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, $ mn 73
Figure 45. Global Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, $ mn 74
Figure 46. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, $ mn 75
Figure 47. Global Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, $ mn 76
Figure 48. Global Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, $ mn 77
Figure 49. Global Oral Antibiotics Market: Other Applications, 2019-2030, $ mn 78
Figure 50. Breakdown of Global Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 79
Figure 51. Global Addressable Market Cap in 2020-2030 by Drug Type, Value ($ bn) and Share (%) 80
Figure 52. Global Oral Antibiotics Market: Brand Antibiotics, 2019-2030, $ bn 81
Figure 53. Global Oral Antibiotics Market: Generic Antibiotics, 2019-2030, $ bn 82
Figure 54.  Global Market Snapshot by Region 83
Figure 55.  Geographic Spread of Worldwide Oral Antibiotics Market, 2019-2030, % of Sales Revenue 84
Figure 56. Global Addressable Market Cap in 2020-2030 by Region, Value ($ bn) and Share (%) 85
Figure 57. Health Spending as a Share of GDP by Country, 2015 and 2030 87
Figure 58.  North American Oral Antibiotics Market, 2019-2030, $ bn 90
Figure 59. Breakdown of North America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 91
Figure 60. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 92
Figure 61. U.S. Oral Antibiotics Market, 2019-2030, $ bn 94
Figure 62. Rising Incidence of Infectious Disease in U.S. 94
Figure 63. Canada Oral Antibiotics Market, 2019-2030, $ bn 97
Figure 64.  Oral Antibiotics Market in Mexico, 2015-2030, $ bn 99
Figure 65.  European Oral Antibiotics Market, 2019-2030, $ bn 102
Figure 66. Breakdown of European Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 103
Figure 67. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 104
Figure 68.  Oral Antibiotics Market in Germany, 2019-2030, $ bn 105
Figure 69.  Oral Antibiotics Market in UK, 2019-2030, $ bn 107
Figure 70.  Oral Antibiotics Market in France, 2019-2030, $ bn 109
Figure 71.  Oral Antibiotics Market in Spain, 2019-2030, $ bn 111
Figure 72.  Oral Antibiotics Market in Italy, 2019-2030, $ bn 113
Figure 73.  Oral Antibiotics Market in Russia, 2019-2030, $ bn 115
Figure 74.  Oral Antibiotics Market in Rest of Europe, 2019-2030, $ bn 117
Figure 75. Asia-Pacific Oral Antibiotics Market, 2019-2030, $ bn 120
Figure 76. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 120
Figure 77. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 122
Figure 78.  Oral Antibiotics Market in Japan, 2019-2030, $ bn 124
Figure 79.  Oral Antibiotics Market in China, 2019-2030, $ bn 126
Figure 80.  Oral Antibiotics Market in Australia, 2019-2030, $ bn 128
Figure 81.  Oral Antibiotics Market in India, 2019-2030, $ bn 130
Figure 82.  Oral Antibiotics Market in South Korea, 2019-2030, $ bn 132
Figure 83.  Oral Antibiotics Market in Rest of APAC, 2019-2030, $ bn 134
Figure 84. South America Oral Antibiotics Market, 2019-2030, $ bn 137
Figure 85. Breakdown of South America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 137
Figure 86. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 138
Figure 87.  Oral Antibiotics Market in Argentina, 2019-2030, $ bn 139
Figure 88.  Oral Antibiotics Market in Brazil, 2019-2030, $ bn 141
Figure 89.  Oral Antibiotics Market in Chile, 2019-2030, $ bn 143
Figure 90.  Oral Antibiotics Market in Rest of South America, 2019-2030, $ bn 145
Figure 91. Oral Antibiotics Market in Middle East and Africa (MEA), 2019-2030, $ bn 147
Figure 92. Breakdown of MEA Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 147
Figure 93. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 148
Figure 94.  Oral Antibiotics Market in UAE, 2019-2030, $ bn 149
Figure 95.  Oral Antibiotics Market in Saudi Arabia, 2019-2030, $ bn 151
Figure 96.  Oral Antibiotics Market in South Africa, 2019-2030, $ bn 153
Figure 97. Growth Stage of Global Oral Antibiotics Industry over the Forecast Period 156

 

 

Reviews

There are yet no reviews for this product.